Your session is about to expire
← Back to Search
BOOST Group for Psychosis
N/A
Waitlist Available
Led By Christopher R Bowie, PhD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at an intervention to help people with psychosis who also have to deal with the negative stereotypes they've internalized about their condition. The intervention is aimed at helping with self-esteem and quality of life. The proposed research would expand the program and make it available to more people.
Who is the study for?
The BOOST trial is for young adults aged 18-35 with conditions like schizophrenia or other psychotic disorders. Participants should be comfortable using computers and phones, not currently abusing substances, and able to read and speak English. Those with neurological issues, significant medical illnesses affecting brain function, physical disabilities impeding participation in the program, recent head injuries, or recent CBT treatment are excluded.
What is being tested?
BOOST is a self-stigma intervention designed to reduce negative self-perceptions in individuals with psychosis. The study aims to enhance this existing program by incorporating more therapeutic techniques and virtual care options to improve its impact on self-esteem and quality of life over the long term while also reaching those in remote areas.
What are the potential side effects?
As BOOST is a psychological intervention rather than a medication, it may not have typical 'side effects'. However, participants might experience emotional discomfort discussing personal experiences related to stigma during group sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Internalized stigma
Secondary study objectives
Generalized Anxiety Disorder scale (GAD-7)
Interpersonal Hopelessness Scale
Interpersonal Needs Questionnaire
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Internalized stigma groupExperimental Treatment1 Intervention
BOOST is an 8 session group intervention, delivered over 4 weeks. The program uses evidence based therapeutic techniques and integrates cognitive behavioural therapy and peer support to reduce or prevent the internalization of stigma in early psychosis. Sessions 1-4 focus on dispelling stigmatizing myths about psychosis and evaluating the accuracy of group members or societies stigmatizing beliefs in order to normalize experiences associated with and reactions to the symptoms of psychosis. Sessions 5-8 teach behavioural approaches for self-empowerment through social skills training, development of assertiveness skills, and goal setting. Role-plays that are specific to young people with psychosis, which were co-developed with people with lived experience, provide opportunities to practice these skills in session. During role plays, participants monitor stigmatizing beliefs that may interfere with communication or pursuing goals.
Find a Location
Who is running the clinical trial?
Queen's UniversityLead Sponsor
373 Previous Clinical Trials
123,966 Total Patients Enrolled
4 Trials studying Schizophrenia
525 Patients Enrolled for Schizophrenia
Christopher R Bowie, PhDPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
75 Total Patients Enrolled
1 Trials studying Schizophrenia
75 Patients Enrolled for Schizophrenia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a physical handicap that stops me from joining the BOOST program.You do not abuse drugs or alcohol.I have a medical condition that affects my brain function.I have been diagnosed with schizophrenia or a similar psychotic disorder.I am between 18 and 35 years old.You are able to understand and communicate in English.
Research Study Groups:
This trial has the following groups:- Group 1: Internalized stigma group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Schizophrenia Patient Testimony for trial: Trial Name: NCT05571228 — N/A
Share this study with friends
Copy Link
Messenger